Drawing for SMART MEDICINE

USPTO serial 77163274

SMART MEDICINE

Reviewed by CopyMark Law Group

Reg. 3958016Status 710
Filing date
Status date
Registration date
May 10, 2011
Examiner
PENDLETON, CAROLYN A
Law office
TMEG LAW OFFICE 103

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with SMART MEDICINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William B. Clemmons Jr.

William B. Clemmons Jr. Smith & Nephew, Inc.1450 Brooks RoadMemphis, TN 38116UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Chemical or biological agents which cause progenitor cells to differentiate into cartilage tissue lineage cells or which cause progenitor cells to differentiate into bone marrow stroma tissue lineage cells, for medical use; pharmaceutical compositions, namely, mesenchymal stem cell (MSC) compositions for the regeneration of cardiac tissue and the treatment of heart disease; pharmaceutical compositions containing mesenchymal stem cells and their bone lineage committed descendants which may be combined with a matrix for bone repair and regeneration; cells for medical use for regeneration of human tissue, namely, bone, cartilage, marrow, muscle, adipose, tissue, and tendon composition; pharmaceutical composition containing mesenchymal stem cells which may be administered intravenously for immune response modulation and to affect tissue repair in treating immune and inflammatory diseaseSECTION 8 - CANCELLEDOct 21, 2010

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 12, 2021CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
May 10, 2020REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sep 18, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 18, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 8, 2017NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jul 8, 2017C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jul 8, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 11, 2017E815TEAS SECTION 8 & 15 RECEIVED
Jul 18, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 18, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 10, 2016REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 7, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 7, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 10, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 5, 2011SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 2, 2011REGVLAW OFFICE REGISTRATION REVIEW COMPLETED
Apr 1, 2011ALIEASSIGNED TO LIE
Apr 1, 2011CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 25, 2011SUPCSTATEMENT OF USE PROCESSING COMPLETE
Feb 21, 2011IUAFUSE AMENDMENT FILED
Feb 21, 2011EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 18, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 17, 2011EX2GSOU EXTENSION 2 GRANTED
Feb 17, 2011AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 1, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 1, 2011EXT2SOU EXTENSION 2 FILED
Aug 4, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 2, 2010EX1GSOU EXTENSION 1 GRANTED
Aug 2, 2010EXT1SOU EXTENSION 1 FILED
Aug 2, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 2, 2010NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 10, 2009NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 10, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 6, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 29, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 29, 2009XAECEXAMINER'S AMENDMENT ENTERED
Sep 29, 2009GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 29, 2009GNEAEXAMINERS AMENDMENT E-MAILED
Sep 29, 2009CNEAEXAMINERS AMENDMENT -WRITTEN
May 8, 2009GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 8, 2009GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 8, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 20, 2009ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 13, 2009PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 2, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 30, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 11, 2009RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sep 8, 2008RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 12, 2008RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 12, 2008ALIEASSIGNED TO LIE
Feb 12, 2008GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 12, 2008GNSLLETTER OF SUSPENSION E-MAILED
Feb 12, 2008CNSLSUSPENSION LETTER WRITTEN
Jan 14, 2008CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 14, 2008COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 11, 2008ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 11, 2008REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 15, 2007GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 15, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 15, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 6, 2007DOCKASSIGNED TO EXAMINER
Apr 26, 2007NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance